Clinical, laboratory, and genetic investigations of hypophosphatasia: support for autosomal dominant inheritance with homozygous lethality.
This article presents detailed clinical and laboratory investigations of six hypophosphatasia kindreds. Serum alkaline phosphatase and urinary phosphoethanolamine comparisons between the affected population and a normal control population demonstrate these parameters routinely identify the heterozygous individual when age and sex variations are accounted for. Using clinical data from the kindred population and a detailed review of the literature, the type and frequency of clinical findings for both the homozygous and heterozygous genotype are enumerated. The clinical and biochemical phenotypes were subjected to segregation analysis. When the results of these analyses are viewed in light of their mathematical limitations and the genetic precepts of autosomal dominant and recessive inheritance, hypophosphatasia is best described as an autosomal dominant disorder with 85% penetrance and homozygous lethality.
D000367:Age Factors; D000469:Alkaline Phosphatase / Q000097:blood / Q000235:genetics; D004983:Ethanolamines / Q000652:urine; D005260:Female; D005799:Genes, Dominant; D005804:Genes, Lethal; D006720:Homozygote; D006801:Humans; D007014:Hypophosphatasia / Q000235:genetics*; D008297:Male; D010375:Pedigree; D010641:Phenotype
D004983:Ethanolamines; C005448:phosphorylethanolamine; D000469:Alkaline Phosphatase